了解加拿大的药物例外使用计划（DEAPs）及其相关的社会和政治问题。

IF 3 1区哲学 Q1 ETHICS

BMC Medical Ethics Pub Date : 2024-03-26 DOI:10.1186/s12910-024-01038-8

Pierre-Marie David, Kayley Laura Lata, Marie-Eve Bouthillier, Jean-Christophe Bélisle-Pipon

引用次数: 0

摘要

加拿大各地都有药品例外获取计划 (DEAP)，以解决药品获取方面的差距。这些计划规避了标准程序，引发了认识论、经济、社会和政治问题。本评论通过揭示这些计划所依赖的背景和程序，对这些问题提出了见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Understanding drug exceptional access programs (DEAPs) in Canada, and their associated social and political issues.

Drug exceptional access programs (DEAPs) exist across Canada to address gaps in access to pharmaceuticals. These programs circumvent standard procedures, raising epistemic, economic, social and political issues. This commentary provides insights into these issues by revealing the context and procedures on which these programs depend.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

BMC Medical Ethics MEDICAL ETHICS-

CiteScore

5.20

自引率

7.40%

发文量

108

审稿时长

>12 weeks

期刊介绍： BMC Medical Ethics is an open access journal publishing original peer-reviewed research articles in relation to the ethical aspects of biomedical research and clinical practice, including professional choices and conduct, medical technologies, healthcare systems and health policies.